Copia Wealth Management’s AbbVie ABBV Stock Holding History

Copia Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$75.7K	Hold	348	–	–	0.05%	157
2025 Q4	$79.5K	Sell	348 -20	-5%	-$4.56K	0.06%	161
2025 Q3	$85.2K	Buy	368 +260	+241%	+$52.9K	0.06%	146
2025 Q2	$20K	Buy	108 +10	+10%	+$1.86K	0.02%	240
2025 Q1	$20.5K	Hold	98	–	–	0.02%	222
2024 Q4	$17.4K	Buy	+98	New	+$18K	0.02%	223

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Copia Wealth Management's ABBV Position: Q1 2026 in Review

Copia Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 348 shares worth $75.7K. The position accounts for 0.05% of the portfolio, ranked #157.

Copia Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $85.2K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Copia Wealth Management held 348 shares of AbbVie worth $75.7K as of Q1 2026.
Copia Wealth Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.05% of Copia Wealth Management's portfolio in Q1 2026, its #157 holding.
Copia Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Copia Wealth Management's AbbVie position peaked at $85.2K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Copia Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.